Novavax NVAX Stock
Novavax Price Chart
Novavax NVAX Financial and Trading Overview
| Novavax stock price | 6.78 USD |
| Previous Close | 9.58 USD |
| Open | 10 USD |
| Bid | 9.68 USD x 1800 |
| Ask | 9.74 USD x 1800 |
| Day's Range | 9.67 - 10.64 USD |
| 52 Week Range | 5.01 - 15.22 USD |
| Volume | 9.21M USD |
| Avg. Volume | 7.84M USD |
| Market Cap | 1.58B USD |
| Beta (5Y Monthly) | 2.5 |
| PE Ratio (TTM) | 4.3738737 |
| EPS (TTM) | 2.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 13.14 USD |
NVAX Valuation Measures
| Enterprise Value | 1.19B USD |
| Trailing P/E | 4.3738737 |
| Forward P/E | -60.6875 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.4620296 |
| Price/Book (mrq) | 41.85345 |
| Enterprise Value/Revenue | 1.106 |
| Enterprise Value/EBITDA | 2.928 |
Trading Information
Novavax Stock Price History
| Beta (5Y Monthly) | 2.5 |
| 52-Week Change | -31.079% |
| S&P500 52-Week Change | 15.00% |
| 52 Week High | 15.22 USD |
| 52 Week Low | 5.01 USD |
| 50-Day Moving Average | 7.18 USD |
| 200-Day Moving Average | 7.71 USD |
NVAX Share Statistics
| Avg. Volume (3 month) | 7.84M USD |
| Avg. Daily Volume (10-Days) | 9.86M USD |
| Shares Outstanding | 162.42M |
| Float | 136.72M |
| Short Ratio | 8.53 |
| % Held by Insiders | 8.75% |
| % Held by Institutions | 58.92% |
| Shares Short | 42.31M |
| Short % of Float | 26.15% |
| Short % of Shares Outstanding | 26.04% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2024 |
| Most Recent Quarter (mrq) | June 30, 2025 |
| Next Fiscal Year End | December 31, 2025 |
Profitability
| Profit Margin | 39.19% |
| Operating Margin (ttm) | 44.16% |
| Gross Margin | 57.18% |
| EBITDA Margin | 37.77% |
Management Effectiveness
| Return on Assets (ttm) | 14.51% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 1.08B USD |
| Revenue Per Share (ttm) | 6.71 USD |
| Quarterly Revenue Growth (yoy) | -42.39% |
| Gross Profit (ttm) | 616.86M USD |
| EBITDA | 407.51M USD |
| Net Income Avi to Common (ttm) | 422.82M USD |
| Diluted EPS (ttm) | 2.22 |
| Quarterly Earnings Growth (yoy) | -34.39% |
Balance Sheet
| Total Cash (mrq) | 612.3M USD |
| Total Cash Per Share (mrq) | 3.77 USD |
| Total Debt (mrq) | 228.49M USD |
| Total Debt/Equity (mrq) | 607.28 USD |
| Current Ratio (mrq) | 2.363 |
| Book Value Per Share (mrq) | 0.232 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -630940992 USD |
| Levered Free Cash Flow (ttm) | -627235008 USD |
Profile of Novavax
| Country | United States |
| State | MD |
| City | Gaithersburg |
| Address | 700 Quince Orchard Road |
| ZIP | 20878 |
| Phone | 240 268 2000 |
| Website | https://www.novavax.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 952 |
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Q&A For Novavax Stock
What is a current NVAX stock price?
Novavax NVAX stock price today per share is 6.78 USD.
How to purchase Novavax stock?
You can buy NVAX shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Novavax?
The stock symbol or ticker of Novavax is NVAX.
Which industry does the Novavax company belong to?
The Novavax industry is Biotechnology.
How many shares does Novavax have in circulation?
The max supply of Novavax shares is 162.5M.
What is Novavax Price to Earnings Ratio (PE Ratio)?
Novavax PE Ratio is 3.37064670 now.
What was Novavax earnings per share over the trailing 12 months (TTM)?
Novavax EPS is 2.01 USD over the trailing 12 months.
Which sector does the Novavax company belong to?
The Novavax sector is Healthcare.
Novavax NVAX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 23470.77 USD — |
-0.52
|
1.89B USD — | 23401.54 USD — | 23531.02 USD — | — - | 1.89B USD — |
| Dow Jones U.S. Biotechnology In DJUSBT | 3190.77 USD — |
-0.13
|
8.16M USD — | 3188.86 USD — | 3201.07 USD — | — - | 8.16M USD — |
| US Tech Biotechnology NBI | 5766.61 USD — |
-0.73
|
— — | 5766.38 USD — | 5799.81 USD — | — - | — — |
| US Tech Health Care IXHC | 1198.83 USD — |
-0.6
|
— — | 1198.83 USD — | 1205.34 USD — | — - | — — |
| US Tech Biotechnology Total Retu XNBI | 6287.52 USD — |
-0.51
|
— — | 6281.92 USD — | 6309.63 USD — | — - | — — |
| US Tech Global Select Market Com NQGS | 11503.4 USD — |
-0.5
|
— — | 11466.94 USD — | 11529.79 USD — | — - | — — |
| Stlmt ID US Tech Biotechnology NBX | 3995.9 USD — |
-4.37
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
| US Tech Composite Total Return XCMP | 28891.43 USD — |
-0.41
|
— — | 28775.95 USD — | 28935.17 USD — | — - | — — |
| US Tech Next Generation 100 Inde NGX | 1509.71 USD — |
-0.62
|
— — | 1507.39 USD — | 1517.45 USD — | — - | — — |
- {{ link.label }} {{link}}